Patrick Blank, Ph.D.
About Patrick Blank, Ph.D.
Patrick Blank, Ph.D., is an Investment Banking Vice President specializing in Biotechnology at Jefferies, with a background in chemistry and extensive experience in the biotech sector.
Current Position at Jefferies
Patrick Blank is currently serving as the Investment Banking Vice President specializing in Biotechnology at Jefferies. He has been in this role since 2022 and is based in the New York City Metropolitan Area. His responsibilities include leveraging his extensive knowledge of protein chemistry and crystallography to analyze equity markets, with a specific focus on the biotechnology sector.
Previous Roles at Jefferies
Before his current position, Patrick Blank worked at Jefferies as an Investment Banking Associate focusing on Biotechnology. He held this role from 2021 to 2022, gaining significant experience in the investment banking field. His work involved detailed market analysis and the application of his chemical expertise to inform financial decisions.
Experience at Credit Suisse
Patrick Blank was an Equity Research Associate in Biotechnology at Credit Suisse from 2019 to 2021. During his two-year tenure, he was responsible for conducting in-depth research on biotechnology companies, analyzing market trends, and providing valuable insights to support investment decisions.
Academic Background
Patrick Blank has a strong academic background in chemistry. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from the University of Pennsylvania, where he studied from 2015 to 2019. He also holds a Master of Science (MS) and a Bachelor of Science (BS) in Chemistry from William & Mary, where he studied from 2013 to 2015 and 2010 to 2013, respectively. His academic achievements provided a solid foundation for his expertise in protein chemistry and crystallography.
Early Career at PBG Healthcare Consulting and University of Pennsylvania
Patrick Blank has accumulated a diverse range of experiences throughout his career. At PBG Healthcare Consulting, he worked in various roles, including Analyst, Manager, and Director, between 2017 and 2019. Additionally, he served as the Vice President of Financial Operations at the University of Pennsylvania from 2018 to 2019. His early career also included a stint as a Doctoral Research Scientist at the University of Pennsylvania, where he worked on protein chemistry and crystallography research.